Advertisement

Neuroprotective Strategies in Epilepsy

  • Peter L. Carlen
  • Marc R. Pelletier
  • Aviv Ouanounou
  • Michael Tymianski
  • Liang Zhang
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 497)

Abstract

It is well known that brain damage can cause epilepsy. Post-traumatic epilepsy (PTE), for instance, is a consequence of traumatic brain injury. The risk of PTE ranges from less than 5 percent of patients following blunt head trauma (e.g., simple skull fracture) to 50 percent in patients following penetrating wounds or those involving intracranial hematoma.11 One of the accepted causes of temporal-lobe epilepsy is perinatal brain injury, which can also lead to other epileptic syndromes, such as West’s syndrome and Lennox-Gastaut syndrome. Epilepsy can also be a presenting symptom of both brain tumors and strokes.

Keywords

Nerve Growth Factor Status Epilepticus Metabotropic Glutamate Receptor Kainic Acid Brain Damage 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Aarli, J.A. Immunological aspects of epilepsy, Brain Development, 15 (1993) 41–50.PubMedGoogle Scholar
  2. 2.
    Abbott, L.C., Nejad, H.H., Bottje, W.G., and Hassan, A.S. Glutathione levels in specific brain regions of genetically epileptic (tg/tg) mice, Brain Research Bulletin, 25 (1990) 629–631.PubMedGoogle Scholar
  3. 3.
    Abe, T., Sugihara, H., Shigemoto, R., Mizuno, N., and Nakanishi, S. Molecular characterization of a novel metabotropic glutamate receptor mGluR5 coupled to inositol phosphate/Ca’ signal transduction, Journal of Biological Chemistry, 267 (1992) 13361–13368.PubMedGoogle Scholar
  4. 4.
    Aicardi, J. and Chevrie, J.J. Convulsive status epilepticus in infants and children: a study of 239 cases, Epilepsia, 11 (1971) 187–197.Google Scholar
  5. 5.
    Albala, B.J., Moshe, S.L., and Okada, R. Kainic acid-induced seizures: a developmental study, Developmental Brain Research, 13 (1984) 139–148.Google Scholar
  6. 6.
    Andrew, R.D. Seizure and acute osmotic change: clinical and neurophysiological aspects, Journal of Neurology, 101 (1991) 7–18.Google Scholar
  7. 7.
    Andrews, P.I., Dichter, M.A., Berkovic, S.F., Newton, M.R., and McNamara, J.O. Plasmapheresis in Rasmussen’s encephalitis, Neurology, 46 (1996) 242–246.PubMedGoogle Scholar
  8. 8.
    Aramori, I. and Nakanishi, S. Signal transduction and pharmacological characteristics of a metabotropic glutamate receptor, mGluR1, in transfected CHO cells, Neuron, 8 (1992) 757–765.PubMedGoogle Scholar
  9. 9.
    Arriizumi, M., Baba, K., Shiihara, H., Ogawa, K., Hibio, S., Hinib, Y, Ryo, S., and Momoki, T. High dose gamma-globulin for intractable childhood epilepsy, Lancet, ii (1983) 162–163.Google Scholar
  10. 10.
    Babb, T.L., Brown, W.J., Pretorius, J., Davenport, C., Lieb, J.P., and Crandall, P.H. Temporal lobe volumetric cell densities in temporal lobe epilepsy, Epilepsia, 25 (1984) 729–740.PubMedGoogle Scholar
  11. 11.
    Babb, T.L. and Pretorious, J.K. Pathologic substrates of epilepsy. In: E. Wylie (Ed.) The treatment of epilepsy: Principles and practice, Lea and Febiger, Philadelphia (1993) pp. 55–70.Google Scholar
  12. 12.
    Barbacid, M. The Trk family of neurotrophin receptors, Journal of Neurobiology, 25 (1994) 1386–1403.PubMedGoogle Scholar
  13. 13.
    Bekenstein, J.W. and Lothman, E.W. Dormancy of inhibitory interneurons in a model of temporal lobe epilepsy, Science, 259 (1993) 97–100.PubMedGoogle Scholar
  14. 14.
    Ben-Ari, Y. Limbic seizure and brain damage produced by kainic acid: mechanisms and relevance to human temporal lobe epilepsy, Neuroscience, 14 (1985) 375–403.PubMedGoogle Scholar
  15. 15.
    Bengzon, J., Kokaia, Z., Elmer, E., Nanobashvili, A., Kokaia, M., and Lindvall, O. Apoptosis and proliferation of dentate gyrus neurons after single and intermittent limbic seizures. Proc. Natl. Acad. Sci. USA, 94 (1997) 10432–10437.PubMedGoogle Scholar
  16. 16.
    Birrell, G.J., Gordon, M.P., and Marcoux, F.W. (1S,3R)-1-aminocyclopentane-1,3-dicarboxylic acid attenuates N-methyl-D-aspartate-induced neuronal cell death in cortical cultures via a reduction in delayed Ca’ accumulation, Neuropharmacology, 32 (1993) 1351–1358.PubMedGoogle Scholar
  17. 17.
    Blaustein, M.P. Calcium transport and buffering in neurons, Trends in Neuroscience, 11 (1988) 438–443.Google Scholar
  18. 18.
    Bleck, T.P. Convulsive disorders: Status epilepticus, Clinical Neuropharmacology, 14 (1991) 191–198.PubMedGoogle Scholar
  19. 19.
    Blennow, G., Brierly, J.B., Meldrum, B.S., and Siesjo, B.K. Epileptic brain damage. The role of systemic factors that modify cerebral energy metabolism, Brain, 101 (1978) 687–700.PubMedGoogle Scholar
  20. 20.
    Boxer, PA., Cordon, J.J., Mann, M.E., Rodolosi, L.C., Vartanian, M.G., Rock, D.M., Taylor, C.P., and Marcoux, F.W. Comparison of phenytoin with non-competitive N-Methyl-D-Aspartate antagonists in model of focal brain ischemia in rat, Stroke, 21 (1990) 47–51.Google Scholar
  21. 21.
    Brorson, J.R., Manzolillo, P.A., and Miller, R.J. Ca’ entry via AMPA/KA receptors and excitotoxicity in cultured cerebellar purkinje cells, Journal of Neuroscience, 14 (1994) 187–197.PubMedGoogle Scholar
  22. 22.
    Bruno, V., Battaglia, G., Copani, A., Giffard, R.G., Raciti, G., Raffaele, R., Shinozaki, H., and Nicoletti, F. Activation of class II or III metabotropic glutamate receptors protects cultured cortical neurons against excitotoxic degeneration, Eur. T. Neurosci., 7 (1995) 1906–1913.Google Scholar
  23. 23.
    Burke, J.P. and Hablitz, J.J. Metabotropic glutamate receptor activation decreases epileptiform activity in rat neocortex, Neuroscience Letters, 174 (1994) 29–33.PubMedGoogle Scholar
  24. 24.
    Carlen, P.L., Perez-Velazquez, J.L., Valiante, T.A., Jahromi, J.J., and Bardakjian, B.L. Electric coupling in epileptogenesis. In: R. Dermietzel and D.C. Spray (Eds.) Gap Junctions in the Nervous System, R.G. Landes Co., Austin [i.e., Georgetown] Tex., (1996).Google Scholar
  25. 25.
    Cavazos, J.E., Das, I., and Sutula, T.P. Neuronal loss induced in limbic pathways by kindling: Evidence for induction of hippocampal sclerosis by repeated brief seizures, J. Neurosci., 14 (1994) 3106–3121.PubMedGoogle Scholar
  26. 26.
    Charriaut-Marlangue, C., Aggoun-Zouaoui, D., Represa, A., and Ben-Ari, Y. Apoptotic features of selective neuronal death in ischemia, epilepsy and gp120 toxicity, Trends Neurosci., 19 (1996) 109–114.PubMedGoogle Scholar
  27. 27.
    Choi, D.W. Calcium-mediated neurotoxicity: relationship to specific channel types and role in ischemic damage, Trends Neurosci., 11 (1988) 465–469.PubMedGoogle Scholar
  28. 28.
    Clifford, D.B., Zorumski, C.F., and Olney, J.W. Ketamine and MK-801 prevent degeneration of thalamic neurons induced by focal cortical seizures, Experimental Neurology, 105 (1989) 272–279.PubMedGoogle Scholar
  29. 29.
    Colwell, C.S., Altemus, K.L., Cepeda, C., and Levine, M.S. Regulation of N-methyl-D-aspartateinduced toxicity in the neostriatum: a role for metabotropic glutamate receptors? Proc. Nall Acad. Sci. USA, 489 (1996) 115–125.Google Scholar
  30. 30.
    Conn, P.J. and Desai, M.A. Pharmacology and physiology of metabotropic glutamate receptors in mammalian central nervous system, Drug Development Research, 24 (1991) 207–229.Google Scholar
  31. 31.
    Connors, B.W, Bernardo, L.S., and Prince, D.A. Coupling between neurons of the developing rat neo-cortex, J Neurosci., 3 (1983) 773–782.PubMedGoogle Scholar
  32. 32.
    Dam, A.M. Epilepsy and neuron loss in the hippocampus, Epilepsia, 21 (1980) 617–629.PubMedGoogle Scholar
  33. 33.
    Daute, K.H., Hassler, A., and Klust, E. Myoklonisch-Astatisches Petit Mal- Immunologische Aspekte in Atiopathogenese and Therapie, IVth Prague International Symposium of Child Neurology, (1978) abstr. p. 16.Google Scholar
  34. 34.
    DeFelipe, J., Sola, R.G., Marco, E, del Rosario del Rio, M., Pulido, P., and Cajal, S.R. Selective changes in the microorganization of the human epileptogenic neocortex revealed by parvalbumin immunoreactivity, Cerebral Cortex, 3 (1993) 39–48.Google Scholar
  35. 35.
    Dermietzel, R. and Spray, D.C. Gap junctions in the brain: where, what type, how many and why? Trends Neurosci., 16 (1993) 186–192.PubMedGoogle Scholar
  36. 36.
    Desai, M.A., McBain, C.J., Kauer, J.A., and Conn, P.J. Metabotropic glutamate receptor-induced dis-inhibition is mediated by reduced transmission at excitatory synapses onto interneurons and inhibitory synapses onto pyramidal cells, Neuroscience Letters, 181 (1994) 78–82.PubMedGoogle Scholar
  37. 37.
    Dragunow, M., Faull, R.L., Lalor, P, Beilharz, E.J., Singleton, K., Walker, E.B., and Mee, E. In situ evidence for DNA fragmentation in Huntington’s disease striatum and Alzheimer’s disease temporal lobes, Neuroreport, 6 (1995) 1053–1057.PubMedGoogle Scholar
  38. 38.
    Dudek, F.E., Obenaus, A., and Tasker, J.G. Osmolality-induced changes in extracellular volume alter epileptiform bursts independent of chemical synapses in the rat: importance of non-synaptic mechanisms in hippocampal epileptogenesis, Neuroscience, 120 (1990) 267–270.Google Scholar
  39. 39.
    Engel, J., Jr. Excitation and inhibition in epilepsy, Can. J Neurol. Sci., 23 (1996) 167–174.Google Scholar
  40. 40.
    Fagan, A.M. and Gage, F.H. Cholinergic sprouting in the hippocampus: A proposed role for IL-I, Experimental Neurology, 100 (1990) 105–120.Google Scholar
  41. 41.
    Ferrer, I., Oliver, B., Russi, A., Casas, R., and Rivera, R. Parvalbumin and calbindin-D28k immunocytochemistry in human neocortical epileptic foci, J Neurol. Sci., 123 (1994) 18–25.PubMedGoogle Scholar
  42. 42.
    Fisher, R.S. Animal models of the epilepsies, Brain Res. Reviews, 14 (1989) 245–278.Google Scholar
  43. 43.
    Fontana, A., Fulpius, B.W., and Cuenoud, S. Antibodies against muscle and brain nicotinic acetylcholine receptors in IgA deficient patients with epilepsy, Adt. Cytopharmacology, 3 (1979) 287–292.Google Scholar
  44. 44.
    Frade, J.M., Rodriguez-T¨¦bar, A., and Barde, Y.-A. Induction of cell death by endogenous nerve growth factor through its p75 receptor, Nature, 383 (1996) 166–168.PubMedGoogle Scholar
  45. 45.
    Frandsen, A., Drejer, J., and Schousboe, A. Direct evidence that excitotoxicity in cultured neurons is mediated via N-methyl-D-aspartate (NMDA) as well as non-NMDA receptors. J. Neurochemistry, 53 (1989) 297–299.Google Scholar
  46. 46.
    Frandsen, A. and Schousboe, A. Dantrolene prevents glutamate cytotoxicity and Ca’’ release from intracellular stores in cultured cerebral cortical neurons, J Neurochemistry, 56 (1991) 1075–1078.Google Scholar
  47. 47.
    Frandsen, A. and Schousboe, A. Excitatory amino acid-mediated cytotoxicity and calcium homeostasis in cultured neurons, J Neurochemistry, 60 (1993) 1202–1210.Google Scholar
  48. 48.
    Freund, T.F., Buzsaki, G., Leon, A., Baimbridge, K.G., and Somogyi, P. Relationship of neuronal vulnerability and calcium binding protein immunoreactivity in ischemia, Exp. Brain Res., 83 (1990) 55–66.Google Scholar
  49. 49.
    Garthwaite, G. and Garthwaite, J. Neurotoxicity of excitatory amino acid receptor agonists in rat cerebellar slices: Dependence on calcium concentration, Neuroscience Letters, 66 (1986) 193–198.PubMedGoogle Scholar
  50. 50.
    Garthwaite, G. and Garthwaite, J. Differential dependence on Ca’-’ of N-methyl-D-aspartate and quisqualate neurotoxicity in young rat hippocampal slices, Neuroscience Letters, 97 (1989) 316–322.PubMedGoogle Scholar
  51. 51.
    Gereau, R.W. IV. and Conn, P.J. Roles of specific metabotropic receptor subtypes in regulation of hippocampal CA1 pyramidal cell excitability, J Neurophysiology, 74 (1995) 122–129.Google Scholar
  52. 52.
    Giulian, D., Chen, J., George, J., and Noponen, M. The role of mononuclear phagocytes in wound healing after traumatic injury to the adult mammalian brain, J. Neuroscience, 9 (1989) 4416–4429.Google Scholar
  53. 53.
    Giulian, D., Johnson, B., Krebs, J.F., George, J., and Tapscott, M. Microglial mitogens are produced in the developing and injured mammalian brain, J. Cell Biology, 112 (1991) 323–333.Google Scholar
  54. 54.
    Giulian, D., Li, J., Leara, B., and Keenen, C., Phagocytic microglia release cytokines and cytotoxins that regulate the survival of astrocytes and neurons in culture, Neurochem. Int., 25 (1994) 227–233.PubMedGoogle Scholar
  55. 55.
    Giulian, D., Li, J., Li, X., George, J., and Rutecki, P.A. The impact of microglia-derived cytokines upon gliosis in the CNS, Dev. Neurosci., 16 (1994) 128–136.PubMedGoogle Scholar
  56. 56.
    Goddard, G.V., McIntyre, D.C., and Leech, C.K. A permanent change in brain function resulting from daily electrical stimulation, Experimental Neurology, 25 (1969) 295–330.PubMedGoogle Scholar
  57. 57.
    Graham, S.H., Chen, J., Lan, J., Leach, M.J., and Simon, R.P. Neuroprotective effects of a use-dependent blocker of voltage-dependent sodium channels, BW619C89, in rat middle cerebral artery occlusion, J. Pharmacol. Exp. Ther., 269 (1994) 854–859.PubMedGoogle Scholar
  58. 58.
    Grau, G.E., Fajardo, L., Piguet, P.F., Allet, B., Lambert, P.H., and Vassalli, P. Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria, Science, 237 (1987) 1210–1212.PubMedGoogle Scholar
  59. 59.
    Greene, C., Schwindt, P, and Crill, W.Metabotropic receptor mediated afterdepolarization in neocortical neurons, Eur. J Pharmacol, 226 (1992) 279–280.PubMedGoogle Scholar
  60. 60.
    Haas, K., Sperber, E.F., and Moshe, S.L. Kindling in developing animals: expression of severe seizures and enhanced development of bilateral foci, Developmental Brain Research, 56 (1990) 275–280.PubMedGoogle Scholar
  61. 61.
    Hablitz, J.J. and Heinemann, U. Extracellular K’ and Cat+ changes during epileptiform discharges in the immature rat neocortex, Brain Res., 433 (1987) 299–303.PubMedGoogle Scholar
  62. 62.
    Hablitz, J.J. and Heinemann, U. Alterations in the microenvironment during spreading depression associated with epileptiform discharges in the immature neocortex, Developmental Brain Research, 46 (1989) 243–252.PubMedGoogle Scholar
  63. 63.
    Hamet, P, Richard, L., Dam, T-V., Teiger, E., Orlov, S.N., Gaboury, L., Gossard, F., and Tremblay, J. Apoptosis in target organs of hypertension, Hypertension, 26 (1995) 642–648.PubMedGoogle Scholar
  64. 64.
    Haraldsson, A., van Engelen, B.G.M., Reiner, W.O., Bakkeren, A.J.M., and Weemaes, C.M.R. Light chain ratios and concentrations of serum immunoglobulins in children with epilepsy, Epilepsy Res., 13 (1992b) 255–260.PubMedGoogle Scholar
  65. 65.
    Haraldsson, A., Weemaes, C.M.R., Koch-Jansen, M.J.H., van Eck-Arts, P.B.J.M., de Boo, T., Bakkeren, J.A.J.M., and Stoelinga, G.B.A. Immunoglobulin G, A and M light chain ration in children. Annals of Clinical Biochemistry, 29 (1992a) 270–274.Google Scholar
  66. 66.
    Hart, Y.M., Cortez, M., Andermann, R, Hwang, P., Fish, D.R., Dulac, O., Silver, K., Fejerman, N., Cross, H., Sherwin, A. et al. Medical treatment of Rasmussen’s syndrome (chronic encephalitis and epilepsy): effect of high-dose steroids or immunoglobulins in 19 patients, Neurology, 44 (1995) 1030–1036.Google Scholar
  67. 67.
    Hengartner, M.O., Ellis, R.E., and Horvitz, H.R. Caenorhabditis elegans gene ced-9 protects cells from programmed cell death, Nature, 356 (1992) 494–499.PubMedGoogle Scholar
  68. 68.
    Hengartner, M.O. and Horvitz, H.R. C elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bc1–2, Cell, 76 (1994) 665–676.PubMedGoogle Scholar
  69. 69.
    Herreras, O., Largo, C., Ibarz, J.M., Somjen, G.G., and Martin del Rio, R. Role of neuronal synchronizing mechanisms in the propagation of spreading depression in the in vivo hippocampus, J. Neuroscience, 14 (1994) 7087–7098.Google Scholar
  70. 70.
    Hochman, D.W., Baraban, S.C., Owens, J.W., and Schwartzkroin, P.A. Dissociation of synchronization and excitability in furosemide blockade of epileptiform activity, Science, 270 (1995) 99–102.PubMedGoogle Scholar
  71. 71.
    Holmes, G.L. and Thompson, J.L. Effects of kainic acid on seizure susceptibility in the developing brain, Developmental Brain Research, 39 (1988) 51–59.Google Scholar
  72. 72.
    Hoshino, C., Yotsumiya, N., and Yata, J. Relationship between anti-GA1 antibody and CNS destructions in nervous diseases, Acta Pediatrica Japon, 86 (1982) 1694.Google Scholar
  73. 73.
    Inoue, K., Morimoto, K., Sato, K., Yamada, N., and Otsuki, S. Mechanisms in the development of limbic status epilepticus and hippocampal neuronal loss: An experimental study in a model of status epilepticus induced by kindling-like electrical stimulation of the deep prepyriform cortex in rats, Acta Medica Okayama, 46 (1992) 129–139.PubMedGoogle Scholar
  74. 74.
    Kairiss, E.W., Racine, R.J., and Smith, G.K. The development of the interictal spike during kindling in the rat, Brain Res., 322 (1984) 101–110.PubMedGoogle Scholar
  75. 75.
    Kaplan, D.R. and Stephens, R.M.Neurotrophin signal transduction by the Trk receptor, J. Neurobiology, 25 (1994) 1404–1417.Google Scholar
  76. 76.
    Kapur, J. and Lothman, E.W. Loss of inhibition precedes delayed spontaneous seizures in the hippocampus after tetanic electrical stimulation, J Neurophysiology, 61 (1989) 427–434.Google Scholar
  77. 77.
    Kapur, J., Stringer, J.L., and Lothman, E.W. Evidence that repetitive seizures in the hippocampus cause a lasting reduction of GABAergic inhibition, J Neurophysiology, 61 (1989) 417–426.Google Scholar
  78. 78.
    Karpiak, S.E., Graf, L., and Rapport, M.M. Antiserum to brain gangliosides produces recurrent epileptiform activity, Science, 194 (1976) 735–737.PubMedGoogle Scholar
  79. 79.
    Kerr, J.F.R., Wyllie, A.H., and Currie, A.R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics, Br. J Cancer, 26 (1972) 239–257.PubMedGoogle Scholar
  80. 80.
    Kiedrowski, L., Brooker, G., Costa, E., and Wroblewski, J.T. Glutamate impairs neuronal calcium extrusion while reducing sodium gradient, Neuron, 12 (1994) 295–300.PubMedGoogle Scholar
  81. 81.
    Koh, J., Palmer, E., and Cotman, C.W. Activation of the metabotropic glutamate receptor attenuates N-methyl-D-aspartate neurotoxicity in cortical cultures, Proc. Natl Acad. Sci., 88 (1991) 9431–9437.Google Scholar
  82. 82.
    Laffont, F., Esnault, S., Gilbert, A., Peytour, M.A., Cathala, H.P., and Eygonnet, J.P. Effet des gammaglobulines sur des epelepsies rebelles, Ann. Med. Int. 130 (1979) 307–312.Google Scholar
  83. 83.
    Li, Y, Sharov, V.G., Jiang, N., Zaloga, C., Sabbah, H.N., and Chopp, M. Ultrastructural and light microscopic evidence of apoptosis after middle cerebral artery occlusion in the rat, Am. J. Pathology, 146 (1995) 1045–1051.Google Scholar
  84. 84.
    Linnik, M.D., Zobrist, R.H., and Hatfield, M.D. Evidence supporting a role for programmed cell death in focal cerebral ischemia in rats, Stroke, 24 (1993) 2002–2008.PubMedGoogle Scholar
  85. 85.
    Lothman, E. The biochemical basis and pathophysiology of status epilepticus, Neurology, 40 (Supp1.2) (1990) 13–23.PubMedGoogle Scholar
  86. 86.
    Lothman, E.W. and Bertram, E.H. III. Epileptogenic effects of status epilepticus, Epilepsia, 34 (Suppl.1) (1993) S59–S70.PubMedGoogle Scholar
  87. 87.
    Lothman, E.W. and Collins, R.C. Kainic acid induced limbic seizures: Metabolic, behavioral, electroencephalographic and neuropathological correlates, Brain Res., 218 (1981) 299–318.PubMedGoogle Scholar
  88. 88.
    Lowenstein, D.H., Seren, M.S., and Longo, F.M. Prolonged increases in neurotrophic activity associated with kainate-induced hippocampal synaptic reorganization, Neuroscience, 56 (1993) 597–604.PubMedGoogle Scholar
  89. 89.
    Lukas, W. and Jones, K.A. Cortical neurons containing calretinin are selectively resistant to calcium overload and excitotoxicity in vitro, Neuroscience, 61 (1994) 307–316.PubMedGoogle Scholar
  90. 90.
    Maiese, K., Swiriduk, M., and TenBroeke, M. Cellular mechanisms of protection by metabotropic glutamate receptors during anoxia and nitric oxide toxicity, J. Neurochemistry, 66 (1996) 2419–2428.Google Scholar
  91. 91.
    Mayer, M.L. and Westbrook, G.L. The physiology of excitatory amino acids in the vertebrate central nervous system, Progress in Neurobiology, 28 (1987) 197–276.PubMedGoogle Scholar
  92. 92.
    Maytal, J., Shinnar, S., Moshe, S.L., and Alvarez, L.A. Low morbidity and mortality of status epilepticus in children, Pediatrics, 83 (1989) 323–331.PubMedGoogle Scholar
  93. 93.
    McBain, C.J., DiChiara, T.J., and Kauer, J.A. Activation of metabotropic glutamate receptors differentially affects two classes of hippocampal interneurons and potentiates excitatory synaptic transmission, J Neuroscience, 14 (1994) 4433–4445.Google Scholar
  94. 94.
    McDonald, J.W., Fix, A.S., Tizzano, J.P., and Schoepp, D.D. Seizures and brain injury in neonatal rats induced by 1S,3R-ACPD, a metabotropic glutamate receptor agonist, J. Neuroscience, 13 (1993) 4445–4455.Google Scholar
  95. 95.
    McDonald, J.W. and Schoepp, D.D. The metabotropic excitatory amino acid receptor agonist 1S,3RACPD selectively potentiates N-methyl-D-aspartate-induced brain injury, Eur. J. Pharmacology, 215 (1992) 353–354.Google Scholar
  96. 96.
    McIntyre, D.C., Nathanson, D., and Edson, N. A new model of partial status epilepticus based on kindling, Brain Res., 250 (1982) 53–63.PubMedGoogle Scholar
  97. 97.
    Meldolesi, J., Volpe, P., and Pozzan, T. The intracellular distribution of calcium, Trends Neurosci., 11 (1988) 449–452.PubMedGoogle Scholar
  98. 98.
    Meldrum, B.S. Metabolic factors during prolonged seizures and their relation to nerve cell death. In: A.V. Delgado-Escueta, C.G. Wasterlain, D.M. Treiman, and R.J. Porter (Eds.) Advances in Neurology. Status epilepticus: mechanisms of brain damage and treatment, vol 34. Raven, New York (1983) pp. 261–275.Google Scholar
  99. 99.
    Meldrum, B. and Garthwaite, J. Excitatory amino acid neurotoxicity and neurodegenerat¨ªve disease, Trends Pharmacol. Sci., 11 (1990) 379–387.Google Scholar
  100. 100.
    Meldrum, B., Vigouroux, R., and Brierley, J. Systemic factors and epileptic brain damage: prolonged seizures in paralyzed artificially ventilated baboons, Arch. Neurology Psychology, 29 (1973) 82–87.Google Scholar
  101. 101.
    Meldrum, B.S. and Brierly, J.B. Prolonged epileptic seizures in primates: ischemic cell damage and its relation to ictal physiological events, Arch. Neurology, 28 (1973) 10–17.Google Scholar
  102. 102.
    Merlin, L.R., Taylor, G.W., and Wong, R.K. Role of metabotropic glutamate receptor subtypes in the patterning of epileptiform activities in vitro, J. Neurophysiology, 74 (1995) 896–900.Google Scholar
  103. 103.
    Merril, J.E. Tumour necrosis factor alpha, interleukin 1 and related cytokines in brain development: Normal and pathological, Developmental Neuroscience, 14 (1992) 1–10.Google Scholar
  104. 104.
    Meyer, F.B. Calcium, neuronal hyperexcitability and ischemic injury. Brain Res. Reviews, 14 (1989) 227–243.Google Scholar
  105. 105.
    Meyer, F.B., Tally, P.W, Anderson, R.E., Sundt, T.M. Jr., Yaksh, T.L., and Sharbrough, F.W. Inhibition of electrically induced seizures by a dihydropyridine calcium channel blocker, Brain Res., 384 (1986) 180–183.PubMedGoogle Scholar
  106. 106.
    Miller, R.J. Calcium signalling in neurons, Trends Neurosci., 11 (1988) 415–419.PubMedGoogle Scholar
  107. 107.
    Miller, R.J. The control of neuronal Ca’ homeostasis, Progress in Neurobiology, 37 (1991) 255–285.PubMedGoogle Scholar
  108. 108.
    Miller, S., Kesslack, J.P., Romano, C., and Cotman, C.W. Roles of metabotropic glutamate receptors in brain plasticity and pathology, Annals of the New York Academy of Sciences, 757 (1995) 460–474.PubMedGoogle Scholar
  109. 109.
    Mintz, M., Rapoport, R., Oleske, J.M., Connor, E.M., Koenigsberger, M.R., Denny, T., and Epstein, L.G. Elevated serum levels of tumour necrosis factor reassociated with progressive encephalopathy in children with acquired immunodeficiency syndrome, Am. J. Diseases in Childhood, 143 (1989) 771–774.Google Scholar
  110. 110.
    Mody, I. and Heinemann, U. NMDA receptors of dentate gyrus granule cells participate in synaptic transmission following kindling, Nature, 326 (1987) 701–704.PubMedGoogle Scholar
  111. 111.
    Monaghan, D.T., Bridges, R.J., and Cotman, C.W. The excitatory amino acid receptors: their classes, pharmacology and distinct properties in the function of the central nervous system, Annual Review of Pharmacology and Toxicology, 29 (1989) 365–402.PubMedGoogle Scholar
  112. 112.
    Nadler, J.V. Kainic acid as a tool for the study of temporal lobe epilepsy, Life Sciences, 29 (1981) 2031–2042.PubMedGoogle Scholar
  113. 113.
    Nakanishi, S. Molecular diversity of glutamate receptors and implications for brain function, Science, 258 (1992) 597–603.PubMedGoogle Scholar
  114. 114.
    Nicotera, P., McConkey, D.J., Dypbukt, J.M., Jones, D.P., and Orrenius, S. Cat*- activated mechanisms in cell killing, Drug Metabolism Review, 20 (1992) 193–201.Google Scholar
  115. 115.
    Nitecka, L., Tremblay, E., Charton, G., Bouillot, J.P., Berger, M.L., and Ben-Ari, Y. Maturation of kainic acid seizure-brain damage syndrome in the rat. II. histopathological sequelae, Neuroscience, 13 (1984) 1073–1094.PubMedGoogle Scholar
  116. 116.
    Olney, J., Rhee, V., and Ho, O. Kainic acid: a powerful neurotoxic analogue of glutamate, Brain Res., 77 (1974) 507–512.PubMedGoogle Scholar
  117. 117.
    Patel, M.N. and McNamara, J.O. Selective enhancement of axonal branching of cultured dentate gyrus neurons by neurotrophic factors, Neuroscience, 69 (1995) 763–770.PubMedGoogle Scholar
  118. 118.
    Payan, J. Anterior transposition of the ulnar nerve: an electrophysiological study, J. Neurol. Neruosurg. Psychiatry, 33 (1970) 157–165.Google Scholar
  119. 119.
    Pechadre, J.C., Sauvezie, B., Osier, C., and Gilbert, J. Traitement des encephalopathies epileptiques de l’enfant par les gammaglobulines, Rev EEG Neurophysiol, 7 (1979) 443–447.Google Scholar
  120. 120.
    Penix, L.P. and Wasterlain, C.G. Selective protection of neuropeptide containing dentate hilar interneurons by non-NMDA receptor blockade in an animal model of status epilepticus, Brain Res., 644 (1994) 19–24.PubMedGoogle Scholar
  121. 121.
    Penner, R., Fasolato, C., and Hoth, M. Calcium influx and its control by calcium release, Current Opinion in Neurobiology, 3 (1993) 368–374.PubMedGoogle Scholar
  122. 122.
    Perez-Velazquez, J.L., Valiante, T.A., and Carlen, P.L. Changes in calcium currents during ethanol withdrawal in a genetic mouse model, Brain Res., 649 (1994) 305–309.PubMedGoogle Scholar
  123. 123.
    Perez-Velazquez, J.L., Valiante, T.A., and Carlen, P.L. Modulation of gap junctional mechanisms during calcium-free induced field burst activity: a possible role for electrotonin coupling in epileptogenesis, J Neurosci., 14 (1994) 4308–4317.PubMedGoogle Scholar
  124. 124.
    Perez-Velazquez, J.L. and Zhang, L. In vitro hypoxia induces expression of the NR2C subunit of the NMDA receptor in rat cortex and hippocampus, J. Neurochem., 63 (1994) 1171–1173.PubMedGoogle Scholar
  125. 125.
    Pin, J.P. and Duvoisin, R. The metabotropic glutamate receptors: structure and functions. Neuropharmacology, 34 (1995) 1–26.PubMedGoogle Scholar
  126. 126.
    Portera-Cailliau, C., Price, D.L., and Martin, L. Brain maturity and selective glutamate receptor subtype activation influence excitotoxic neuronal death morphology along an apoptosis-necrosis continuum, Society of Neuroscience abstract, Washington, DC 589 (1996) 1.Google Scholar
  127. 127.
    Pretel, S., Applegate, C.D., and Piekut, D. Apoptotic and necrotic cell death following kindling induced seizures. Acta Histochem., 99 (1997) 71–79.PubMedGoogle Scholar
  128. 128.
    Racine, R.J., Mosher, M., and Kairiss, E.W. The role of the piriform cortex in the generation of interictal spikes in the kindled preparation, Brain Res., 454 (1988) 251–263.PubMedGoogle Scholar
  129. 129.
    Rahman, S. and Neuman, R.S. Characterization of metabotropic glutamate receptor-mediated facilitation of N-methyl-D-aspartate depolarization of neocortical neurones, Br. J. Pharmacology, 117 (1996) 675–683.Google Scholar
  130. 130.
    Randall, R.D. and Thayer, S.A. Glutamate-induced calcium transient triggers delayed calcium overload and neurotoxicity in rat hippocampal neurons, J. Neuroscience, 12 (1992) 1882–1895.Google Scholar
  131. 131.
    Rashid, K., Van der Zee, C.E., Ross, G.M., Chapman, C.A., Stanisz, J., Riopelle, R.J., Racine, R.J., and Fahnestock, M. A nerve growth factor peptide retards seizure development and inhibits neuronal sprouting in a rat model of epilepsy, Proc. Natl Acad. Sci. USA, 92 (1995) 9495–9499.PubMedGoogle Scholar
  132. 132.
    Rasool, N., Muzzafar, M.D., and Rubinstein, E.H. Lidocaine accelerates neuroelectrical recovery after incomplete global ischemia in rabbits, Stroke, 21 (1990) 929–935.PubMedGoogle Scholar
  133. 133.
    Rayport, S.G. and Kandel, E.R. Epileptogenic agents enhance transmission at an identified weak electrical synapse in aplysia, Science, 213 (1981) 462–464.PubMedGoogle Scholar
  134. 134.
    Recasens, M. and Vignes, M. Excitatory amino acid metabotropic receptor subtypes and calcium regulation, Annals of the New York Academy of Sciences, 757 (1995) 418–429.PubMedGoogle Scholar
  135. 135.
    Represa, A., Niquet, J., Pollard, H., and Ben-Ari, Y. Cell death, gliosis, and synaptic remodelling in the hippocampus of epileptic rats, J Neurobiology, 26 (1995) 413–425.Google Scholar
  136. 136.
    Rogers, S.W, Andrews, P.I., Gahring, L.C., Whisenand, T., Cauley, K., Crain, B., Hughes, T.E., Heinemann, S.F., and McNamara, J.O. Autoantibodies to glutamate receptor G1uR3 in Rasmussen’s encephalitis, Science, 265 (1994) 648–651.PubMedGoogle Scholar
  137. 137.
    Roper, S.N., Obenaus, A., and Dudek, F.E. Osmolality and nonsynaptic epileptiform bursts in rat CAl and dentate gyrus, Annals of Neurology, 31 (1992) 81–85.PubMedGoogle Scholar
  138. 138.
    Rothman, S.M. and Olney, J.W. Glutamate and the pathophysiology of hypoxic-ischemic brain damage, Annals of Neurology, 19 (1986) 105–111.PubMedGoogle Scholar
  139. 139.
    Sacaan, A.I. and Schoepp, D.D. Activation of hippocampal metabotropic excitatory amino acid receptors leads to seizures and neuronal damage, Neuroscience Letters, 139 (1992) 77–82.PubMedGoogle Scholar
  140. 140.
    Sato, K., Kashihara, K., Morimoto, K., and Hayabara, T. Regional increases in brain-derived neurotrophic factor and nerve growth factor mRNAs during amygdaloid kindling, but not in acidic and basist growth factor mRNAs, Epilepsia, 37 (1996) 6–14.PubMedGoogle Scholar
  141. 141.
    Sato, M., Racine, R.J., and McIntyre, D.C. Kindling: basic mechanisms and clinical validity, Electroencephalography Clin. Neurophysiof, 76 (1990) 459–472.Google Scholar
  142. 142.
    Scharfman, H.E. and Schwartzkroin, PA. Protection of dentate hilar cells from prolonged stimulation by intracellular calcium chelation, Science, 246 (1989) 257–260.PubMedGoogle Scholar
  143. 143.
    Schmidt, J. New aspects in the pharmacology of kindling implications for mechanism of action in kindling, Polish J Pharmacol. Pharmacy, 39 (1987) 527–536.Google Scholar
  144. 144.
    Schmutz, M. Relevance of kindling and related processes to human epileptogenesis, Progress in Neuropsychopharmacology and Biological Psychiatry, 11 (1987) 505–525.Google Scholar
  145. 145.
    Schoepp, D.D. The biochemical pharmacology of metabotropic glutamate receptors, Biochemical Society Transactions, 21 (1993) 97–102.PubMedGoogle Scholar
  146. 146.
    Schoepp, D.D. and Conn, P.J. Metabotropic glutamate receptors in brain function and pathology, Trends Pharmacol. Sci., 14 (1993) 13–20.Google Scholar
  147. 147.
    Schwartzkroin, P.A. Epileptogenesis in the immature central nervous system. In: P.A. Schwartzkroin and H.V. Wheal (Eds.) Electrophysiology of epilepsy: Academic Press, London (1984) pp. 389–412.Google Scholar
  148. 148.
    Sheardown, M.J. Metabotropic glutamate receptor agonists reduce epileptiform activity in the rat neo-cortex, NeuroReport, 3 (1992) 916–918.PubMedGoogle Scholar
  149. 149.
    Shigemoto, R., Nakanishi, S.. and Mizuno, N. Distribution of the mRNA for a metabotropic glutamate receptor (mGluR1) in the central nervous system: An in situ hybridization study in adult and developing rat, J Comp. Neurology, 322 (1992) 121–135.Google Scholar
  150. 150.
    Siesjo, B.K. Basis for the application of calcium antagonists in neurology: calcium in the brain under physiological and pathological conditions, Eur. Neurology, 30 (1990) 3–9.Google Scholar
  151. 151.
    Siesjo, B.K. and Bengtsson, F. Calcium fluxes, calcium antagonists, and calcium-related pathology in brain ischemia, hypoglycemia, and spreading depression: a unifying hypothesis, Journal of Cerebral Blood Flow and Metabolism, 9 (1989) 127–140.PubMedGoogle Scholar
  152. 152.
    Siliprandi, R., Lipartiti, M., Fadda, E., Sautter, J., and Manev, H. Activation of the glutamate metabotropic receptor protects retina against N-methyl-D-aspartate toxicity, Eur. J. Pharmacology, 219 (1992) 173–174.Google Scholar
  153. 153.
    Singh, R. and Pathak, D.N. Lipid peroxidation and glutathione peroxidase, glutathione reductase, superoxide dismutase, catalase, and glucose-6-phosphate dehydrogenase activities in FeC13-induced epileptogenic foci in the rat brain, Epilepsia, 31 (1990) 15–26.PubMedGoogle Scholar
  154. 154.
    Sloviter, R.S. “Epileptic” brain damage in rats induced by sustained electrical stimulation of the perforant path. I. Acute electrophysiological and light microscopic studies, Brain Res. Bulletin, 10 (1983) 675–697.Google Scholar
  155. 155.
    Sloviter, R.S. Decreased hippocampal inhibition and a selective loss of interneurons in experimental epilepsy, Science, 235 (1987) 73–76.PubMedGoogle Scholar
  156. 156.
    Sloviter, R.S. Calcium-binding protein (Calbindin-D28K) and parvalbumin immunocytochemistry: Localization in the rat hippocampus with specific reference to the selective vulnerability of hippocampal neurons to seizure activity, J. Comp. Neurology, 280 (1989) 183–196.Google Scholar
  157. 157.
    Sloviter, R.S. Permanently altered hippocampal structure, excitability and inhibition after experimental status epilepticus in the rat: the “dormant basket cell” hypothesis and its possible relevance to temporal lobe epilepsy, Hippocampus, 1 (1991) 41–46.PubMedGoogle Scholar
  158. 158.
    Sloviter, R.S. and Damiano, B.P. Sustained electrical stimulation of the perforant path duplicates kainate-induced electrophysiological effects and hippocampal damage in rats, Neuroscience Letters, 24 (1981) 279–284.PubMedGoogle Scholar
  159. 159.
    Spray, D.C. and Dermietzel, R. X-linked dominant Charcot-Marie-Tooth disease and other potential gap-junction diseases of the nervous system, Trends Neurosci., 18 (1995) 256–262.PubMedGoogle Scholar
  160. 160.
    Sommer, W. Erkrankung des Ammonshorns als aetiologisches moment der epilepsien, Arch. Psychiatric Nervenkr., 10 (1880) 631–675.Google Scholar
  161. 161.
    Stanton, P.K. and Moskal, J.R. Diphenylhydantoin protects against hypoxia-induced impairment of hippocampal synaptic transmission, Brain Res., 546 (1991) 351–354.PubMedGoogle Scholar
  162. 162.
    Stelzer, A., Slater, N.T., and ten Bruggencate, G. Activation of NMDA receptors blocks GABAergic inhibition in an in vitro model of epilepsy, Nature, 326 (1987) 698–701.PubMedGoogle Scholar
  163. 163.
    Stewart, B.W. Mechanisms of apoptosis: Integration of genetic, biochemical, and cellular indicators, Journal of the National Cancer Institute, 86 (1994) 1286–1296.PubMedGoogle Scholar
  164. 164.
    Stys, P.K., Waxman, S.G., and Ransom, B.R. Ionic mechanisms of anoxic injury in mammalian CNS white matter: role of Na’-Ca’ exchanger, J. Neuroscience, 12 (1992) 430–439.Google Scholar
  165. 165.
    Sutula, T., Cascino, G., Cavazos, J., Parada, I., and Ramirez, L. Mossy fiber synaptic reorganization in the epileptic human temporal lobe, Annals of Neurology, 26 (1989) 321–330.PubMedGoogle Scholar
  166. 166.
    Sutula, T., He, X.X., Cavazos, J., and Scott, G. Synaptic reorganization in the hippocampus induced by abnormal functional activity, Science, 239 (1988) 1147–1150.PubMedGoogle Scholar
  167. 167.
    Taft, W.C., Clifton, G.L., Blair, R.E., and DeLorenzo, R.J. Phenytoin protects against ischemiaproduced neuronal cell death, Brain Res., 483 (1989) 143–148.PubMedGoogle Scholar
  168. 168.
    Tanabe, Y, Masu, M., Ishii, T., Shigemoto, R., and Nakanishi, S. A family of metabotropic glutamate receptors, Neuron, 8 (1992) 169–179.PubMedGoogle Scholar
  169. 169.
    Tanabe, Y., Nomura, A., Masu, M., Shigemoto, R., Mizuno, N., and Nakanishi, S. Signal transduction, pharmacological properties, and expression patterns of two metabotropic glutamate receptors, mGluR3 and mGluR4, J. Neuroscience, 13 (1993) 1372–1378.Google Scholar
  170. 170.
    Taschenberger, H., Roy, B.L., and Lowe, D.A. Effects of a metabotropic glutamate agonist, trans-ACPD, on cortical epileptiform activity, NeuroReport, 3 (1992) 629–632.PubMedGoogle Scholar
  171. 171.
    Tasker, J.G. and Dudek, F.E. Electrophysiology of GABA-mediated synaptic transmission and possible roles in epilepsy, Neurochemical Res., 16 (1991) 251–262.Google Scholar
  172. 172.
    Tasker, R.C., Coyle, J.T., and Vornov, J.J. The regional vulnerability to hypoglycemia-induced neurotoxicity in organotypic hippocampal culture: protection by early tetrodotoxin or delayed MK-801, J. Neuroscience, 12 (1992) 4298–4308.Google Scholar
  173. 173.
    Taylor, C.P. and Meldrum, B.S. Na’ channels as targets for neuroprotective drugs, TiPS, 16 (1995) 309–316.PubMedGoogle Scholar
  174. 174.
    Thomas, R.J. Excitatory amino acids in health and disease, J. Am. Geriatrics Society, 43 (1995) 1279–1289.Google Scholar
  175. 175.
    Thompson, C.B. Apoptosis in the pathogenesis and treatment of disease, Science, 267 (1995) 1456–1462.PubMedGoogle Scholar
  176. 176.
    Tizzano, J.P., Griffey, K.I., Johnson, J.A., Fix, A.S., Helton, D.R., and Schoepp, D.D. Intracerebral 1S,3R-dicarboxylic acid (1S,3R-ACPD) produces limbic seizures that are not blocked by ionotropic glutamate receptor antagonists, Neuroscience Letters, 162 (1993) 12–16.PubMedGoogle Scholar
  177. 177.
    Traynelis, S.F. and Dingledine, R. Role of extracellular space in hyperosmotic suppression of potassium-induced electrographic seizures, J. Neurophysiology, 61 (1989) 927–938.Google Scholar
  178. 178.
    Triggs, W.J. and Willmore, L.J. In vivo lipid peroxidation in rat brain following intracortical Fee’ injection, J. Neurochemistry, 42 (1984) 976–980.Google Scholar
  179. 179.
    Twyman, R.E., Gahring, L.C., Spiess, J., and Rogers, S.W. Glutamate receptor antibodies activate a subset of receptors and reveal an agonist binding site, Neuron, 14 (1995) 755–762.PubMedGoogle Scholar
  180. 180.
    Tymianski, M., Wallace, M.C., Spigelman, I., Uno, M., Carlen, P.L., Tator, C.H., and Charlton, M.P. Cell-permeant Ca’-’ chelators reduce early excitotoxic and ischemic neuronal injury in vitro and in vivo, Neuron, 11 (1993) 221–235.PubMedGoogle Scholar
  181. 181.
    Valiante, T.A., Perez-Velazquez, J.L., Jahromi, S.S., and Carlen, P.L. Coupling potential in CAI neurons during calcium-free-induced field burst activity, J. Neurosci., 15 (1995) 6946–6956.PubMedGoogle Scholar
  182. 182.
    Van der Zee, C.E., Rashid, K., Le, K., Moore, K.A., Stanisz, J., Diamond, J., Racine, R.J., and Fahnestock, M. Intraventricular administration of antibodies to nerve growth factor retards kindling and blocks mossy fiber sprouting in adult rats, J. Neuroscience, 15 (1995) 5316–5323.Google Scholar
  183. 183.
    Vecil, G.G., Li, P.P., and Warsh, J.J. Evidence for metabotropic excitatory amino acid receptor heterogeneity: Developmental and brain regional studies, J Neurochemistry, 59 (1992) 252–258.Google Scholar
  184. 184.
    Vicedomini, J.P. and Nadler, J.V. A model of status epilepticus based on electrical stimulation of hippocampal afferent pathways, Experimental Neurology, 96 (1987) 681–691.PubMedGoogle Scholar
  185. 185.
    Vicedomini, J.P. and Nadler, J.V. Stimulation-induced status epilepticus: role of hippocampal mossy fibers in the seizures and associated neuropathology, Brain Res., 521 (1990) 70–74.Google Scholar
  186. 186.
    Walton, N.Y Systemic effects of generalized convulsive status epilepticus, Epilepsia, 34 (1993) S54–S58.PubMedGoogle Scholar
  187. 187.
    Wasterlain, C.G., Fujikawa, D.G., Penix, L., and Sankar, R. Pathophysiological mechanisms of brain damage from status epilepticus, Epilepsia, 34 (Suppl.1) (1993) S37–S53.PubMedGoogle Scholar
  188. 188.
    Watkins, J.C., Krogsgaard-Larsen, P., and Honore, T. Structure-activity relationships in the development of excitatory amino acid receptor agonists and competitive antagonists, Trends Pharmacol. Sci., 11 (1990) 25–33.Google Scholar
  189. 189.
    Weber, M.L. and Taylor, C.P. Damage from oxygen and glucose deprivation in hippocampal slices is prevented by tetrodotoxin, lidocaine and phenytoin without blockade of action potentials, Brain Res., 664 (1994) 167–177.PubMedGoogle Scholar
  190. 190.
    Weiss, J.H., Koh, J.Y., Baimbridge, K.G., and Choi, D.W. Cortical neurons containing somatostatin-or parvalbumin-like immunoreactivity are atypically vulnerable to excitotoxic injury in vitro, Neurology, 40 (1990) 1288–1292.PubMedGoogle Scholar
  191. 191.
    White, E. Life, death, and the pursuit of apoptosis, Genes and Development, 10 (1996) 1–15.PubMedGoogle Scholar
  192. 192.
    Willmore, L.J., Ballinger, W.E. Jr., Boggs, W, Sypert, G.W., and Rubin, J.J. Dendritic alterations in rat isocortex within an iron-induced chronic epileptic focus, Neurosurgery, 7 (1980) 142–146.PubMedGoogle Scholar
  193. 193.
    Willmore, L.J., Hiramatsu, M., Kochi, H., and Mori, A. Formation of superoxide radicals after FeCh injection into rat isocortex, Brain Res., 277 (1983) 393–396.PubMedGoogle Scholar
  194. 194.
    Willmore, L.J. and Rubin, J.J. Antiperoxidant pretreatment and iron-induced epileptiform discharges in the rat: EEG and histopathologic studies, Neurology, 31 (1981) 63–69.Google Scholar
  195. 195.
    Willmore, L.J. and Triggs, W.J. Effect of phenytoin and corticosteroids on seizures and lipid peroxidation in experimental posttraumatic epilepsy, J Neurosurgery, 60 (1984) 467–472.Google Scholar
  196. 196.
    Yamasaki, Y., Kogure, K., Hara, H., Ban, H., and Akaike, N. The possible involvement of tetrodotoxinsensitive ion channels in ischemic neuronal damage in the rat hippocampus, Neuroscience Letters, 121 (1991) 251–254.PubMedGoogle Scholar
  197. 197.
    Yuan, J.Y. and Horvitz, H.R. The Caenorhabditis elegans genes ced-3 and ced-4 act autonomously to cause programmed cell death, Developmental Biology, 138 (1990) 33–41.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2000

Authors and Affiliations

  • Peter L. Carlen
    • 1
  • Marc R. Pelletier
    • 1
  • Aviv Ouanounou
    • 1
  • Michael Tymianski
    • 1
  • Liang Zhang
    • 1
  1. 1.The Toronto Western HospitalTorontoCanada

Personalised recommendations